US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 3.220
  • +0.230+7.69%
Close Nov 6 16:00 ET
  • 3.220
  • 0.0000.00%
Post 16:21 ET
673.34MMarket Cap-2025P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allogene Therapeutics Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
10.00K
-76.74%
EPS
-0.33
+11.49%
Analyst Rating
Strong Buy

Nov 6, 2024

Allogene Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 947.500K --
Nov 7, 2024 2024/Q3 -- / 10.000K --
Aug 7, 2024 2024/Q2 0.000 / 1.777M --
May 13, 2024 2024/Q1 22.000K / 10.430K --
Mar 14, 2024 2023/Q4 21.000K / 22.400K --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 947.500K--
Nov 7, 20242024/Q3-- / 10.000K--
Aug 7, 20242024/Q20.000 / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--

Unlock Free Earnings Estimates

Allogene Therapeutics Earnings Reports

  • Allogene Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 04:14

  • Allogene Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 14 04:07

  • Allogene Therapeutics | 10-K: FY2023 Annual Report

    Mar 15 05:00

  • Allogene Therapeutics | 10-K/A: Annual report (Amendment)

    Mar 15 04:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      81.82%

    • Hold

      18.18%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data